Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11)
Publication
, Conference
Desjardins, A; Barboriak, D; Herndon, JE; Reardon, D; Quinn, J; Rich, J; Sathornsumetee, S; Friedman, H; Vredenburgh, J
Published in: NEURO-ONCOLOGY
October 1, 2007
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2007
Volume
9
Issue
4
Start / End Page
573 / 574
Location
Dallas, TX
Publisher
DUKE UNIV PRESS
Conference Name
12th Annual Meeting of the Society-for-Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A., Barboriak, D., Herndon, J. E., Reardon, D., Quinn, J., Rich, J., … Vredenburgh, J. (2007). Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11). In NEURO-ONCOLOGY (Vol. 9, pp. 573–574). Dallas, TX: DUKE UNIV PRESS.
Desjardins, Annick, Daniel Barboriak, James E. Herndon, David Reardon, Jennifer Quinn, Jeremy Rich, Sith Sathornsumetee, Henry Friedman, and James Vredenburgh. “Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11).” In NEURO-ONCOLOGY, 9:573–74. DUKE UNIV PRESS, 2007.
Desjardins A, Barboriak D, Herndon JE, Reardon D, Quinn J, Rich J, et al. Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11). In: NEURO-ONCOLOGY. DUKE UNIV PRESS; 2007. p. 573–4.
Desjardins, Annick, et al. “Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11).” NEURO-ONCOLOGY, vol. 9, no. 4, DUKE UNIV PRESS, 2007, pp. 573–74.
Desjardins A, Barboriak D, Herndon JE, Reardon D, Quinn J, Rich J, Sathornsumetee S, Friedman H, Vredenburgh J. Evaluation of tumor response by dynamic contrast-enhanced magnetic resonance imaging in glioblastoma (gbm) patients treated with bevacizumab (bev) and irinotecan (CPT-11). NEURO-ONCOLOGY. DUKE UNIV PRESS; 2007. p. 573–574.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
October 1, 2007
Volume
9
Issue
4
Start / End Page
573 / 574
Location
Dallas, TX
Publisher
DUKE UNIV PRESS
Conference Name
12th Annual Meeting of the Society-for-Neuro-Oncology
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences